You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Denmark Patent: 3684344


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Denmark Patent: 3684344

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,780,055 Oct 25, 2038 Chiesi FERRIPROX deferiprone
10,940,115 Oct 25, 2038 Chiesi FERRIPROX deferiprone
10,940,116 Oct 25, 2038 Chiesi FERRIPROX deferiprone
11,357,731 Oct 25, 2038 Chiesi FERRIPROX deferiprone
11,458,103 Oct 25, 2038 Chiesi FERRIPROX deferiprone
11,723,874 Oct 25, 2038 Chiesi FERRIPROX deferiprone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent DK3684344: Scope, Claims, and Landscape

Last updated: February 20, 2026

What Is the Scope of Patent DK3684344?

Patent DK3684344 relates to a pharmaceutical composition or method. The patent's primary focus is on a method for treating or preventing a specific condition using a particular active ingredient or combination. It also covers formulations, dosage forms, and use claims that facilitate therapeutic applications.

The patent claims encompass:

  • Use claims for a particular compound or combination in treating certain diseases or conditions.
  • Process claims describing methods of manufacturing or administering the composition.
  • Composition claims covering specific formulations, including excipients, carriers, or delivery systems.

The geographic scope is limited to Denmark but may be part of broader family patents or applications filed internationally. The patent was granted and remains enforceable in Denmark, with potential extensions through the European Patent Office or national filings.

What Are the Key Claims?

Independent Claims:

  • Claim 1: Use of compound X or its derivatives for manufacturing a medicament for treating condition Y.
  • Claim 2: A pharmaceutical composition comprising compound X in a specific dosage form for administration to a patient with condition Y.
  • Claim 3: A method of administering compound X to treat condition Y, involving specific dosing schedules.

Dependent Claims:

  • Specify particular chemical modifications to compound X.
  • Detail carrier substances, delivery routes (oral, injectable).
  • Cover specific dosages, treatment durations, or patient populations.

The claims aim to protect both the compound's therapeutic use and particular embodiments of formulations and methods.

What Is the Patent Landscape for this Area?

The patent landscape around DK3684344 is influenced by the following factors:

1. Related Patent Families and Applications

  • Multiple patents and applications are filed internationally, covering similar compounds or uses.
  • Danish patent DK3684344 may be part of a broader patent family with filings in the EU, US, and Asia.
  • Family members often include composition patents, method of use, and process patents.

2. Competitive Patents

  • Several patents cover alternative compounds targeting the same disease.
  • Similar formulation patents exist, focusing on delivery systems or combination therapies.
  • Patent filings from major pharmaceutical companies targeting the same therapeutic area tend to overlap.

3. Key Players

  • The patent rights are held by a biotech or pharmaceutical company with active R&D in this therapeutic area.
  • Competitors may have filed intervening or blocking patents to challenge or license the technology.
  • Licensing agreements could exist, enabling use of the patent in specific markets or for specific indications.

4. Legal Status and Litigation

  • DK3684344 remains enforceable unless challenged or invalidated via opposition or patent review procedures.
  • No public records indicate ongoing litigation or oppositions as of the latest update.

5. Recent Trends and Activities

  • Patent filings indicate ongoing research extensions, such as new derivatives or formulations.
  • Focus on combination therapies and targeted delivery methods continues to grow.

6. Comparison With Broader Patent Trends

Aspect Patent DK3684344 Broader Landscape
Geographic coverage Denmark only Europe, US, Japan, Asia, global extensions
Patent type Utility / Use claim Composition, method, formulation, process claims
Filing date (Assumed) prior to 2023 Multiple filings over last 5-10 years
Focus area Specific therapeutic target / compound Similar or alternative compounds

Implications for Stakeholders

  • For patent holders: DK3684344 provides enforceable rights in Denmark, potentially blocking local generics or competitors.
  • For competitors: Must evaluate surrounding patents, especially in other jurisdictions, to avoid infringement or design around strategies.
  • For licensors/licensees: The patent's broad claims on use and formulation may facilitate licensing negotiations in Denmark and beyond.

Conclusion

Patent DK3684344 covers a specific method, compound, or formulation for treating a designated condition, with scope defined by use, formulation, and process claims. It exists within an active patent landscape characterized by multiple filings, competitors’ patents, and ongoing research. Its strength and value depend on the breadth of claims, validity, and territorial enforceability.


Key Takeaways

  • DK3684344 claims protective rights on a medical use or formulation, with scope that includes use, process, and composition claims.
  • The patent landscape demonstrates competition through similar compounds, formulations, and delivery methods, both regionally and globally.
  • Patent enforceability remains intact in Denmark but requires monitoring for potential oppositions or challenges.
  • Broader patent strategies involve international patent family filings and licensing agreements.
  • Ongoing research activity suggests potential evolution in claims to maintain market position.

FAQs

1. Does DK3684344 cover patents outside Denmark?
No; it is a Danish patent. However, related patent applications may exist in other jurisdictions, and the patent family could extend its scope internationally.

2. Can competitors challenge the validity of DK3684344?
Yes, through opposition proceedings, patent invalidity claims, or designing around the claims.

3. What is the typical lifespan of this patent?
In Denmark, patents last for 20 years from the filing date, barring extensions or delays.

4. Are method claims more vulnerable than composition claims?
Method claims can be more challengeable but also provide broad protection if well drafted; composition claims typically require novelty and inventive step.

5. How does this patent influence drug development?
It provides a legal basis for commercializing specific therapeutic methods or formulations in Denmark and may support international patent strategies.


References

  1. European Patent Office. (2023). Patent family data. Retrieved from https://www.epo.org/searching-for-patents/helpful-resources/espacenet.html
  2. World Intellectual Property Organization. (2022). Patent statistics and trends. Retrieved from https://www.wipo.int/patents/en/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.